Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM.

Adv Nutr. 2015 Sep 15;6(5):513-40. doi: 10.3945/an.114.007732. Print 2015 Sep. Review.

2.

N-glycosylation site occupancy in human prostaglandin H synthases expressed in Pichia pastoris.

Kukk K, Kasvandik S, Samel N.

Springerplus. 2014 Aug 15;3:436. doi: 10.1186/2193-1801-3-436. eCollection 2014.

3.

Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.

Kirkby NS, Chan MV, Lundberg MH, Massey KA, Edmands WM, MacKenzie LS, Holmes E, Nicolaou A, Warner TD, Mitchell JA.

FASEB J. 2013 Oct;27(10):3938-46. doi: 10.1096/fj.12-215533. Epub 2013 Jun 21.

4.

Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults.

Trappe TA, Carroll CC, Dickinson JM, LeMoine JK, Haus JM, Sullivan BE, Lee JD, Jemiolo B, Weinheimer EM, Hollon CJ.

Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R655-62. doi: 10.1152/ajpregu.00611.2010. Epub 2010 Dec 15.

5.

Transcellular biosynthesis of eicosanoids.

Sala A, Folco G, Murphy RC.

Pharmacol Rep. 2010 May-Jun;62(3):503-10. Review.

6.

Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans.

Burd NA, Dickinson JM, Lemoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders CE Jr, Trappe TA.

Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E354-61. doi: 10.1152/ajpendo.00423.2009. Epub 2009 Nov 24.

7.
8.

Cyclooxygenase-2 and its regulation in inflammation.

Bakhle YS, Botting RM.

Mediators Inflamm. 1996;5(5):305-23. No abstract available.

10.

Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.

Gopez JJ, Yue H, Vasudevan R, Malik AS, Fogelsanger LN, Lewis S, Panikashvili D, Shohami E, Jansen SA, Narayan RK, Strauss KI.

Neurosurgery. 2005 Mar;56(3):590-604.

11.

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation.

Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW.

J Exp Med. 2004 Jul 5;200(1):69-78.

12.

Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica.

Dey I, Keller K, Belley A, Chadee K.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13561-6. Epub 2003 Oct 29.

13.

Non-steroidal anti-inflammatory drugs and bladder cancer prevention.

Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK.

Br J Cancer. 2000 Apr;82(7):1364-9.

14.

Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.

Watkins MT, Patton GM, Soler HM, Albadawi H, Humphries DE, Evans JE, Kadowaki H.

Biochem J. 1999 Dec 15;344 Pt 3:747-54.

15.
16.

Kinetic basis for selective inhibition of cyclo-oxygenases.

Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC.

Biochem J. 1999 May 1;339 ( Pt 3):607-14.

17.

Aspirin use and potential mechanisms for colorectal cancer prevention.

Williams CS, Smalley W, DuBois RN.

J Clin Invest. 1997 Sep 15;100(6):1325-9. Review. No abstract available.

18.

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN.

J Clin Invest. 1997 May 1;99(9):2254-9.

19.

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Tsujii M, Kawano S, DuBois RN.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3336-40.

20.

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA.

J Clin Invest. 1996 Jun 1;97(11):2672-9.

Supplemental Content

Support Center